Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-02 · accession 0001562180-25-004346 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-06-03 | 2025-06-02 | UTHR | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $325.83 | -12.0K | 16.1K | -43% | -$3.91M |
| DT | 2025-06-03 | 2025-06-02 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +12.0K | 20.1K | +148% | +$1.41M |
| DT | 2025-06-03 | 2025-06-02 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -12.0K | 99.5K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | S | D | 2,603 | $325.54 | 17,515 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $325.00 to $325.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-06-02 | M | A | 12,000 | $117.76 | 20,118 | D | — | — | (F2) Includes 50 shares of common stock acquired on March 4, 2025 under the United Therapeutics Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2025-06-02 | S | D | 2,653 | $326.31 | 8,118 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $326.00 to $326.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-06-02 | S | D | 5,347 | $325.59 | 10,771 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $325.00 to $325.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2025-06-02 | S | D | 1,397 | $326.34 | 16,118 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $326.00 to $326.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | Stock Option | 2025-06-02 | M | D | 12,000 | $0.00 | 99,500 | D | $117.76 · 2021-03-15 to 2027-03-15 | 12,000 Common Stock |